New lab: A meeting of the minds to improve chronic lung diseases
Bolstered by the support of more than $30 million, researchers at the MGH are now teaming up with colleagues at Brigham and Women’s Hospital and the German pharmaceutical company Bayer AG to study new drug options for chronic lung diseases.